Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

OBJECTIVE: We sought to investigate the long-term outcomes of patients who develop immune checkpoint inhibitor (ICI)-induced inflammatory arthritis (IA), to define factors associated with IA persistence after ICI cessation, the need for immunosuppressants and the impact of these medications on under...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Braaten, Tawnie J, Brahmer, Julie R, Forde, Patrick M, Le, Dung, Lipson, Evan J, Naidoo, Jarushka, Schollenberger, Megan, Zheng, Lei, Bingham, Clifton O, Shah, Ami A, Cappelli, Laura C
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7031780/
https://ncbi.nlm.nih.gov/pubmed/31540935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2019-216109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados